# FacePhys

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/facephys

- Industry: Software
- Headquarters: Beijing, China
- Website: www.facephys.com
- Latest round: Angel (Jun 10, 2026)
- Investors on record: 1

## About

FacePhys, based in Beijing, China, focuses on innovative physiological monitoring technology that enables contactless heart rate detection and vital signs analysis for diverse applications in health monitoring and smart technology.Founded in 2025 in Beijing, FacePhys specializes in physiological monitoring technology. The company has completed one funding deal, raising an undisclosed amount of Angel funding from Shunwei Capital in June 2025. The founder’s history is currently not available, and there are no known subsidiaries or parent companies.FacePhys specializes in advanced physiological monitoring technology, providing a suite of products that focus on contactless heart rate detection and vital signs analysis. Their core offerings include the FacePhys Console, which integrates real-time heart rate analysis, heart rate variability (HRV) measurements, and emotional state detection through on-device processing, ensuring user privacy with no raw video uploads. The technology is designed for a variety of end-use cases, such as smart homes, wearables, and ergonomics labs, catering to sectors like health monitoring, mental health, and user experience testing. The company partners with prestigious institutions such as Tsinghua University and MIT, serving a global customer base that spans various markets including North America, Europe, and Asia. The company’s solutions are particularly useful in research settings, private deployments, and smart technology applications.FacePhys generates revenue through a structured API and SDK sales model that caters to both B2B and B2C clients. The company offers various API plans that allow clients to select services tailored to their needs, creating a subscription-based revenue stream. Transaction structures may involve direct purchases of the FacePhys Console and associated software tools, enabling clients in sectors like healthcare and technology to integrate heart rate detection capabilities into their products. Clients can also access offline SDKs for on-device physiological sensing, facilitating additional purchase opportunities for integrated hardware-software solutions. Specific pricing details for these plans and products are determined based on client needs and the scale of deployment, with options for sample units and bulk procurement available for larger institutional customers.FacePhys plans to utilize the Angel funding raised in June 2025 to accelerate research and development as well as the industrialization process in the field of AI machine vision. The company is also focusing on expanding into new markets, targeting regions in North America and Europe by the end of 2026. Upcoming products are in the design phase, with specific launch dates to be announced.

## Funding rounds

- Angel, Jun 10, 2026 — Shunwei Capital

## Investors

- Shunwei Capital (https://capitalatlas.ai/funds/shunwei-capital) — Angel